Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Merck & Co (NY:MRK)

83.92 +5.34 (+6.80%)
Streaming Delayed Price Updated: 3:41 PM EDT, Sep 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 15,232,425
Open 78.42
Bid (Size) 83.92 (4)
Ask (Size) 83.93 (6)
Prev. Close 78.58
Today's Range 78.39 - 83.93
52wk Range 73.31 - 114.79
Shares Outstanding 2,531,374,696
Dividend Yield 3.86%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
What's going on in today's session: S&P500 movers
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Tuesday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
Merck (MRK) Shares Skyrocket, What You Need To Know
Shares of global pharmaceutical company Merck (NYSE:MRK) jumped 5.7% in the afternoon session after the company announced positive results from its Phase 3 HYPERION trial for its drug, WINREVAIR™... 
Via StockStory
Topics Artificial Intelligence

Performance

YTD
-15.4%
-15.4%
1 Month
-1.8%
-1.8%
3 Month
+6.0%
+6.0%
6 Month
-6.5%
-6.5%
1 Year
-26.1%
-26.1%

More News

Read More
Tech Revolutionizes Cattle Feeding: A Sustainable Future for Livestock Markets
Via MarketMinute
Topics Artificial Intelligence Climate Change Emissions
IO Biotech Stock Plunges After FDA Recommends Another Trial For Investigational Cancer Vaccine
Via Stocktwits
Pharmaceutical Tariffs ‘A Light At The End Of The Trump Tunnel’ For Big Pharma, Says Jefferies
Via Stocktwits
Topics Government
Evaxion Stock Jumps A Whopping 43% Pre-Market – Here’s What Happened
Via Stocktwits
Discover which S&P500 stocks are making waves on Tuesday.
Via Chartmill
Merck's Winrevair Cuts Clinical Worsening Risk By 76% Among Hypertension Patients
Via Benzinga
Merus N.V. Soars on $8 Billion Genmab Acquisition, Propelled by Oncology Pipeline Successes
Via MarketMinute
WINREVAIR™ (sotatercept-csrk) Reduced the Risk of Clinical Worsening Events by 76% Compared to Placebo in Patients Recently Diagnosed With PAH on Background Therapy in Phase 3 HYPERION Trial
From Merck Sharp & Dohme
Via Business Wire
Pharma Lobby Announces New Website To Connect Patients With Manufacturer-Direct Purchase Program
Via Stocktwits
Topics Government
U.S. Government Teeters on Brink of Shutdown: Markets Brace for Uncertainty Amidst Data Blackout Fears
Via MarketMinute
Topics Bonds Economy Government
Johnson & Johnson's Hypothetical Rally: A Look at Potential 2025 Valuation Drivers
Via MarketMinute
Topics Economy Intellectual Property
Healthcare Sector Reels: A Deep Dive into Thursday's -1.67% Plunge
Via MarketMinute
Topics Economy
Trump's 100% Pharmaceutical Tariff: The $270 Billion Manufacturing War That Could Reshape Your Medicine Cabinet
Via Benzinga
Topics Government World Trade
Prediction: 2 Stocks That Will Be Worth More Than BigBear.ai 5 Years From Now
Via The Motley Fool
Topics Artificial Intelligence
Robert F. Kennedy Jr. Faces Impeachment Push From Haley Stevens Over 'Health Care Chaos' And Rising Costs: 'Enough Is Enough'
Via Benzinga
Trump Shocks Pharma With 100% Tariff On Imported Drugs Unless Companies Build In America
Via Stocktwits
Topics Government
Moderna Stands By UK As Pharma Giants Criticize Pricing, UK Secures First Onshore mRNA Vaccine Production Centre
Via Benzinga
Peering Into Merck & Co's Recent Short Interest
Via Benzinga
Merck & Co. Inc. (NYSE:MRK): A Prime Candidate for a Dependable Dividend Portfolio
Via Chartmill
United Kingdom The Worst European Country For Drug Prices: Eli Lilly CEO
Via Benzinga
The Smartest Dividend Stock to Buy With $1,000 Right Now
Via The Motley Fool
Topics Intellectual Property
Should You Forget Pfizer and Buy These Unstoppable Stocks Instead?
Via The Motley Fool
Topics Intellectual Property
3 Dividend Stocks Perfect for Millennial Investors
Via The Motley Fool
Topics Economy Intellectual Property Retirement

Frequently Asked Questions

Is Merck & Co publicly traded?
Yes, Merck & Co is publicly traded.
What exchange does Merck & Co trade on?
Merck & Co trades on the New York Stock Exchange
What is the ticker symbol for Merck & Co?
The ticker symbol for Merck & Co is MRK on the New York Stock Exchange
What is the current price of Merck & Co?
The current price of Merck & Co is 83.92
When was Merck & Co last traded?
The last trade of Merck & Co was at 09/30/25 03:41 PM ET
What is the market capitalization of Merck & Co?
The market capitalization of Merck & Co is 212.45B
How many shares of Merck & Co are outstanding?
Merck & Co has 212B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.